GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conformis Inc (NAS:CFMS) » Definitions » EBIT

Conformis (Conformis) EBIT : $-39.02 Mil (TTM As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Conformis EBIT?

Conformis's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2023 was $-12.31 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was $-39.02 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Conformis's annualized ROC % for the quarter that ended in Jun. 2023 was -136.20%. Conformis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -149.43%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Conformis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -214.36%.


Conformis EBIT Historical Data

The historical data trend for Conformis's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conformis EBIT Chart

Conformis Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.95 -25.49 -21.88 1.17 -48.48

Conformis Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.17 -14.65 -3.11 -8.95 -12.31

Competitive Comparison of Conformis's EBIT

For the Medical Devices subindustry, Conformis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conformis's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conformis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Conformis's EV-to-EBIT falls into.



Conformis EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-39.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Conformis  (NAS:CFMS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Conformis's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

ROC % (Q: Jun. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2023 ) + Invested Capital (Q: Jun. 2023 ))/ count )
=-49.22 * ( 1 - -0.24% )/( (36.889 + 35.562)/ 2 )
=-49.338128/36.2255
=-136.20 %

where

Note: The Operating Income data used here is four times the quarterly (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Conformis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2023  Q: Jun. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-49.248/( ( (13.756 + max(19.943, 0)) + (12.614 + max(19.601, 0)) )/ 2 )
=-49.248/( ( 33.699 + 32.215 )/ 2 )
=-49.248/32.957
=-149.43 %

where Working Capital is:

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.672 + 19.49 + 1.671) - (7.248 + 0.716 + 1.926)
=19.943

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(7.797 + 19.024 + 1.616) - (6.037 + 0.585 + 2.214)
=19.601

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Conformis's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2023 )
=-39.024/18.205
=-214.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Conformis EBIT Related Terms

Thank you for viewing the detailed overview of Conformis's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Conformis (Conformis) Business Description

Traded in Other Exchanges
N/A
Address
600 Technology Park Drive, Billerica, MA, USA, 01821
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Executives
Christine Desrochers officer: Fmr Interim CFO & Controller 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Gary P Fischetti director 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Mark A Augusti director, officer: FORMER PRESIDENT & CEO 40 WEST HIGHLAND PARK DRIVE NE, HUTCHINSON MN 55350
Denise E Pedulla officer: FORMER CLO & SECRETARY 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Philip W Johnston director C/O CONFORMIS INC, 600, BILLERICA MA 01821
Carrie Bienkowski director C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Robert S Howe officer: CFO & TREASURER C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
J Brent Alldredge officer: CLO & SECRETARY C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Fallon Kenneth P Iii director 5473 FOX HOLLOW DRIVE, NAPLES FL 34101
Erin Henry officer: CORP CONTROLLER & INTERIM PAO C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Frederick W Driscoll officer: INTERIM CFO & INTERIM TREAS
Paul S Weiner officer: Chief Financial Officer C/O CONFORMIS INC, 28 CROSBY DRIVE, BEDFORD MA 01730
Archon Capital Management Llc 10 percent owner 1100 19TH AVENUE EAST, SEATTLE WA 98112
Patricia A Davis officer: CLO & GENERAL COUNSEL C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 02181
Bradley Langdale director C/O CONFORMIS, INC., 28 CROSBY DRIVE, BEDFORD MA 01730